ESR1 and breast carcinoma: ASCO, American Society of Clinical Oncology; EGTM, European Group on Tumor Markers; ER+, Estrogen-receptor-positive; ESMO, European Society for Medical Oncology; NCCN, National Comprehensive Cancer Network; DBCG, Danish Breast Cancer Group; CCTG, Canadian Cancer Trials Group.